Cardiovasc Intervent Radiol (2017) 40:1421–1430 DOI 10.1007/s00270-017-1650-0 CLINICAL INVESTIGATION NON-VASCULAR INTERVENTIONS Percutaneous Treatment of Non-parasitic Splenic Cysts: Long-Term Results for Single- Versus Multiple-Session Treatment 1 2 1 • • • Okan Akhan Merve Gulbiz Dagoglu-Kartal Turkmen Ciftci 3 4 1 • • Cigdem Ozer Aysun Erbahceci Devrim Akinci Received: 13 November 2016 / Accepted: 4 April 2017 / Published online: 1 May 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017 Abstract Recurrence and reduction rates were evaluated for two Purpose The aim of this study was to investigate the groups. efﬁcacy and safety of percutaneous sclerotherapy for non- Results Technical success rate was 100%. The mean fol- parasitic splenic cysts (NPSCs). The secondary aims were low-up period was 68.9 months. Recurrence detected in 7 to introduce puncture-aspiration-injection-reaspiration (29.1%) patients. Final reduction rate was between 40.7 (PAIR) technique in the treatment of NPSCs and to com- and 100% (median 96.4%) with a signiﬁcant difference in pare multiple- and single-session techniques. cyst volume (p \ 0.05). There was no signiﬁcant differ- Materials and Methods This retrospective study included ence regarding recurrence rates (p = 1) and the ﬁnal 24 (17 females, 7
CardioVascular and Interventional Radiology – Springer Journals
Published: May 1, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera